BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 17681240)

  • 1. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
    Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
    Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer.
    Gaztañaga M; Cambeiro M; Villafranca E; Vila M; Jurado M; Moreno M; Martínez-Monge R
    Brachytherapy; 2012; 11(2):119-24. PubMed ID: 21684815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
    Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
    Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
    Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
    Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
    Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
    Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
    Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
    Solhjem MC; Petersen IA; Haddock MG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
    DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
    Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
    Chong I; Hoskin PJ
    Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
    Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
    Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
    Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME
    Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.